Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E27P | ISIN: CA30053H1055 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
EVOME MEDICAL TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
EVOME MEDICAL TECHNOLOGIES INC 5-Tage-Chart

Aktuelle News zur EVOME MEDICAL TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.08.Evome Medical Technologies Inc: Evome Medical details low-capex plan for revenue1
15.08.Evome Medical Technologies Inc.: Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan118Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical...
► Artikel lesen
13.08.EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer-
12.08.Evome Medical Technologies reports Q2 results1
12.08.Evome Medical Technologies Inc.: Evome Medical Technologies Reports Second Quarter 2024 Financial Results462Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug....
► Artikel lesen
03.07.EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer2
03.07.Evome Medical Technologies Inc: Evome hires IR Labs for investor relations1
03.07.Evome Medical Technologies Inc.: Evome Medical Technologies Retains irlabs for Investor Relations Services1
03.07.Evome Medical Technologies Inc: Evome Medical 504,286 shares for debt1
17.06.EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer1
14.06.Evome Medical Technologies Inc: Evome receives conditional OK for shares for services1
14.06.Evome Medical Technologies Inc.: Evome Medical Technologies Announces Securities Issuances1
03.06.Evome Medical Technologies Inc: Evome Medical estimates April, May revenue1
03.06.Evome Medical Technologies Inc.: Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q21
01.06.EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer-
30.05.Evome Medical Technologies Inc: Evome Medical talks Biodex revenue growth1
30.05.Evome Medical Technologies Inc.: Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt111NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue...
► Artikel lesen
23.04.EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer1
12.04.Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled109NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's...
► Artikel lesen
01.04.Evome Medical Technologies Inc.: Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023125NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023....
► Artikel lesen
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1